PharmSource /home.asp

Sitemap / Contact

Home

About

Products/Services

News & Articles

Events

ADVANTAGE Home

DOWNLOAD Entire Issue

Analytical Services

	•	Avalon and CoGenesys Executives Form Nobel Life Sciences
	•	AAIPharma Services Opens New Lab Facility in North Carolina
	•	Almac Completes Expansion of Facilities at Headquarters

API - Biomanufacturing

	•	DSM BioSolutions Enters Contract with Novacta Biosystems
	•	Xcellerex Begins Construction of New Facility
	•	BioProtein Raises USD 643,000 from Shareholders
	•	Alpha Biologics Announces Plans of New Laboratories
	•	BioVectra Plans to Expand Services

API - Small Molecule

	•	Galilaeus Oy Expands Contract Manufacturing Facility
	•	Surya Pharma Plans to Raise USD 100 Million
	•	Parabolic Drugs Plans to Enter CRAMS Sector
	•	LAB Research Announces GLP Certification
	•	Lonza Launches New Services
	•	Albemarle Announces Plans to Build Kilo Lab
	•	Ash Stevens Plans Expansion of Riverview Facility
	•	Evonik Opens China API Facility
	•	Ubichem Research Receives cGMP Approval

Business Conditions

	•	Russian Pharma Landscape Ripens for CMOs and CROs
	•	Tax Credit Provides Unique Opportunity for CROs and CMOs
	•	Q1 Review: Growth Subdued, but Still Positive

Clinical Manufacturing and Packaging

	•	ISP Upgrades Lab
	•	Colorcon Upgrades Technical Services for Laboratory
	•	Isogen’s Lab Services Offered in Auction
	•	Eurofins Scientific Plans to Issue Bonds
	•	Enavail Announces Plans to Build Manufacturing Facility
	•	Aptuit Raises USD 467,000 in Private Offering
	•	Depots Key Element in Clinical Logistics Competition

Commercial Dose Manufacturing

	•	Nycomed Maintains Contract Manufacturing Presence in Latin America
	•	CPL to Close Buffalo Site
	•	Pharmalucence Plans Production Facility
	•	Patheon Enters into an Expanded Contract with Merck
	•	Kemwell Announces Opening of Manufacturing Center
	•	Hameln Pharma Increases Capacity at New Plant
	•	DPT Labs Completes Expansion Project
	•	Aveva Receives Warning Letter from FDA
	•	Accupac Upgrades and Expands Facilities
	•	Corden Buys BMS Site
	•	AMRI buys Hyaluron
	•	Panacea Biotec Receives FDA Approval
	•	Piramal Sells Domestic Business, CMO Unit Now the Focus
	•	The Chao Center for Industrial Pharmacy and Contract Manufacturing Discontinues Operations

Commercial Packaging

•

MNX Opens Distribution Center in Australia

Drug Discovery

•

OriGene Announces Plans to Build Center in China

Early Development (Preclinical/Phase I)

	•	PRA Opens New Phase I Facility
	•	CRL-WuXi Deal Challenged by Investor Group

Emerging Markets

	•	EMOR July 2010: Local Market Developments
	•	Emerging Markets 2010: Download Entire Issue

Phase II-IV Clinical Services

	•	Kendle Opens New Operations Center
	•	Covance Announces Opening of New Facility
	•	Medpace Announces CAP Accreditation
	•	Chiltern Establishes New Offices
	•	Max Neeman Expands Portfolio with the Addition of Lab Services
	•	Parexel Opens Offices in China

Side Effects

	•	July 2010: Side Effects
	•	June 2010: Side Effects

SEARCH by Service Provider

SEARCH by Client

Analytical Services

	•	Analytical chemistry and stability
	•	Bioanalytical testing
	•	Biosafety and product characterization
	•	Microbiology
	•	Particle characterization

API - Biomanufacturing

	•	Cell culture
	•	Fermentation
	•	Oligonucleotides
	•	Peptides
	•	Purification only

API - Small Molecule

	•	Ingredient finishing (milling, coating, etc.)
	•	Small Molecule API Manufacturing
	•	Solid state chemistry

Clinical Dose Manufacturing and Packaging

	•	Clinical Labels
	•	Clinical Packaging and Distribution
	•	Comparator Sourcing
	•	Injectable Phase I/II CTM and Formulation
	•	Solid, Semi-solid/Liquid Phase I/II CTM and Form

Commercial Dose Manufacturing

	•	Inhalation dose form manufacturing
	•	Injectables manufacturing
	•	Semi-solid & liquid manufacturing
	•	Soft gelatin capsules manufacturing
	•	Solid dose manufacturing
	•	Sterile non-injectable products manufacturing
	•	Transdermal dose form manufacturing

Commercial Packaging

•

Commercial packaging

Consulting Services

	•	Project and sourcing management services
	•	Regulatory, Validation and QA Services
	•	Staffing and recruitment

Phase II - IV Clinical Services

•

Central laboratory services

Industry Analysis

	•	*ANY or ALL CATEGORIES*
	•	Analytical Services Market
	•	API - Biomanufacturing Market
	•	API - Small Molecule Market
	•	Business conditions
	•	Clinical Manufacturing and Packaging Market
	•	Commercial Dose Manufacturing Market
	•	Commercial Packaging
	•	Commodity Suppliers
	•	Discovery Services Market
	•	Early Development Market (Preclinical/Phase I)
	•	Emerging Markets
	•	Outsourcing Strategies
	•	Phase II-IV Clinical Services Market
	•	Regulatory issues in Outsourcing
	•	Technology

Sourcing and Supply Chain Practices

	•	*ANY or ALL CATEGORIES*
	•	Contract and Legal Issues
	•	Performance management and QA
	•	Project Management
	•	Relationship Management
	•	Risk management
	•	Sourcing practices

Read the latest musings from PharmSource

Privacy Policy / License Agreement / Secure Update